MAZE logo
MAZE NASDAQ US

Maze Therapeutics, Inc. - Common Stock

Healthcare · Pharmaceuticals Website · IPO Jan 2025
$28.71
▼ $-0.34 (-1.17%)
Vol 780K
3
Quality Score
fail
Mkt Cap
$2.0B
ROE
-19.2%
D/E
0.00
Beta
0.99
52W
$7–$43

Wall Street Consensus

12 analysts · Apr 2026
5
Strong Buy
6
Buy
1
Hold
0
Sell
0
Strong Sell
91.7%
Buy Rating

Price Chart

Similar Stocks

RAPP
Rapport Therapeutics Inc
$1.4B
HRMY
Harmony Biosciences Holdings Inc
P/E 11.6
$2.2B
MBX
MBX Biosciences Inc
$1.4B
TRVI
Trevi Therapeutics Inc
$1.6B
ATAI
AtaiBeckley Inc
$1.5B
HROW
Harrow Inc
$1.8B
SEPN
Septerna Inc
$1.2B
EYPT
EyePoint Inc
$1.5B
COLL
Collegium Pharmaceutical Inc
P/E 25.0
$1.5B

Earnings

Beat rate: 60.0%
Quarter EPS Est EPS Act Surprise
Dec 2025 $-0.73 $-0.65 +$0.08
Sep 2025 $-0.72 $-0.66 +$0.06
Jun 2025 $-0.87 $-0.77 +$0.10
Mar 2025 $-0.77 $-1.15 $-0.38

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -14.0% — -14.0% -14.0% -19.2% -19.2%
P/E (TTM) — 32.17 — — — —
Net Margin — — — — — —
Gross Margin — — — — — —
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 13.63 16.10 13.63 13.63 17.70 17.70

Key Ratios

ROA (TTM)
-16.7%
EPS (TTM)
$-1.20
52W High
$43.29
52W Low
$6.71
$6.71 52-Week Range $43.29

How does MAZE compare to Pharmaceuticals peers?

Peer group: Micro-cap Pharmaceuticals (All) · 171 companies

MAZE AARD ACB ACRS ADIL

MAZE valuation vs Pharmaceuticals peers

P/E ratio
—
▼ 0% below peers (22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼ 0% below peers (5.0)
vs Peers
vs Industry
Overvalued
P/B ratio
—
▼ 0% below peers (2.1)
vs Peers
vs Industry
Overvalued
Div yield
—
▼ 0% below peers (2.0%)
vs Peers
vs Industry
Low yield

MAZE profitability vs Pharmaceuticals peers

ROE
-19.2%
▲ 65% above peers (-54.3%)
vs Peers
vs Industry
Below avg
Net margin
—
▼ 0% below peers (-47.4%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼ 0% below peers (68.3%)
vs Peers
vs Industry
In line
ROA
-16.7%
▲ 55% above peers (-37.4%)
vs Peers
vs Industry
Below avg

MAZE financial health vs Pharmaceuticals peers

D/E ratio
0.0
▼ 100% below peers (1.5)
vs Peers
vs Industry
Low debt
Current ratio
17.7
▲ 427% above peers (3.4)
vs Peers
vs Industry
Strong liquidity
Beta
1.0
▲ 5% above peers (0.9)
vs Peers
vs Industry
Less volatile

MAZE fundamentals radar

MAZE Peer median Industry

MAZE profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

MAZE vs peers: key metrics

Latest News

Maze Therapeutics President Sells All Insider Shares as Q4 Earning Report Nears
Nasdaq · Mar 22